47776e2c
2022-01-06
👍
After-Hours Stock Movers: Berkeley Lights, Sutro Biopharma, BioNTech SE and more
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":695851697,"tweetId":"695851697","gmtCreate":1641425964609,"gmtModify":1641425964828,"author":{"id":4092698747642690,"idStr":"4092698747642690","authorId":4092698747642690,"authorIdStr":"4092698747642690","name":"47776e2c","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>👍</p></body></html>","htmlText":"<html><head></head><body><p>👍</p></body></html>","text":"👍","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/695851697","repostId":2201559742,"repostType":4,"repost":{"id":"2201559742","kind":"news","pubTimestamp":1641422710,"share":"https://ttm.financial/m/news/2201559742?lang=&edition=full","pubTime":"2022-01-06 06:45","market":"us","language":"en","title":"After-Hours Stock Movers: Berkeley Lights, Sutro Biopharma, BioNTech SE and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2201559742","media":"StreetInsider","summary":"After-Hours Stock Movers:Berkeley Lights, Inc., (Nasdaq: BLI) 25% LOWER; Eric D. Hobbs, Ph.D., the c","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/BLI\">Berkeley Lights</a>, Inc., (Nasdaq: BLI) 25% LOWER; Eric D. Hobbs, Ph.D., the company’s CEO and Board Member, will transition from his role to the president of the Antibody Therapeutics, to focus on growing the company’s largest business line. Provides outlook.</p><p>Sutro Biopharma, Inc. (NASDAQ: STRO) 12.8% LOWER; provided a clinical update from the Company's ongoing, fully enrolled, dose-expansion Phase 1 study of STRO-002, a folate receptor alpha (FolR)-targeting antibody-drug conjugate (ADC), for patients with advanced ovarian cancer. Discussion of these data will be held at a STRO-002 Virtual Event at 2 pm PT/5 pm ET today.</p><p>SomaLogic (NASDAQ: SLGC) 8.1% HIGHER; announced a worldwide strategic collaboration with <a href=\"https://laohu8.com/S/ILMN\">Illumina</a>, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership to better enable and empower proteomics and multi-omics research worldwide. As part of the agreement:</p><p>Magenta Therapeutics, Inc. (NASDAQ: MGTA) 9% HIGHER; upgraded to Buy at Goldman Sachs.</p><p>Turtle Beach Corporation (Nasdaq: HEAR) 4.4% LOWER; expects to report full year 2021 revenue of approximately $365 million, in line with previously provided guidance of $365 to $380 million. Full year Adjusted EBITDA for 2021 is expected to be within, although at the lower end, of the previously provided guidance range of $36 to $44 million reflecting expected revenue. (*Consensus sees FY21 revenue of $374.8 million)</p><p><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (NASDAQ: BNTX) 1.6% HIGHER; CDC Advisers Recommend BioNTech/Pfizer (NYSE: PFE) Booster Shot For Kids Ages 12-17 - Bloomberg.</p><p>Dynavax Technologies (NASDAQ: DVAX) 2.1% HIGHER; Goldman Sachs reinstates coverage with a Buy rating and a price target of $38.00.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Berkeley Lights, Sutro Biopharma, BioNTech SE and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Berkeley Lights, Sutro Biopharma, BioNTech SE and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-06 06:45 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19427154><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Berkeley Lights, Inc., (Nasdaq: BLI) 25% LOWER; Eric D. Hobbs, Ph.D., the company’s CEO and Board Member, will transition from his role to the president of the Antibody ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19427154\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","DVAX":"德纳维制药","BK4548":"巴美列捷福持仓","BK4139":"生物科技","BK4535":"淡马锡持仓","BK4170":"电脑硬件、储存设备及电脑周边","SLGC":"SomaLogic, Inc.","BK4121":"生命科学工具和服务","BK4524":"宅经济概念","STRO":"Sutro Biopharma Inc","BNTX":"BioNTech SE","BK4551":"寇图资本持仓"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19427154","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201559742","content_text":"After-Hours Stock Movers:Berkeley Lights, Inc., (Nasdaq: BLI) 25% LOWER; Eric D. Hobbs, Ph.D., the company’s CEO and Board Member, will transition from his role to the president of the Antibody Therapeutics, to focus on growing the company’s largest business line. Provides outlook.Sutro Biopharma, Inc. (NASDAQ: STRO) 12.8% LOWER; provided a clinical update from the Company's ongoing, fully enrolled, dose-expansion Phase 1 study of STRO-002, a folate receptor alpha (FolR)-targeting antibody-drug conjugate (ADC), for patients with advanced ovarian cancer. Discussion of these data will be held at a STRO-002 Virtual Event at 2 pm PT/5 pm ET today.SomaLogic (NASDAQ: SLGC) 8.1% HIGHER; announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership to better enable and empower proteomics and multi-omics research worldwide. As part of the agreement:Magenta Therapeutics, Inc. (NASDAQ: MGTA) 9% HIGHER; upgraded to Buy at Goldman Sachs.Turtle Beach Corporation (Nasdaq: HEAR) 4.4% LOWER; expects to report full year 2021 revenue of approximately $365 million, in line with previously provided guidance of $365 to $380 million. Full year Adjusted EBITDA for 2021 is expected to be within, although at the lower end, of the previously provided guidance range of $36 to $44 million reflecting expected revenue. (*Consensus sees FY21 revenue of $374.8 million)BioNTech SE (NASDAQ: BNTX) 1.6% HIGHER; CDC Advisers Recommend BioNTech/Pfizer (NYSE: PFE) Booster Shot For Kids Ages 12-17 - Bloomberg.Dynavax Technologies (NASDAQ: DVAX) 2.1% HIGHER; Goldman Sachs reinstates coverage with a Buy rating and a price target of $38.00.","news_type":1,"symbols_score_info":{"BLI":1,"BNTX":1,"DVAX":0.9,"HEAR":1,"MGTA":1,"SLGC":1,"STRO":1}},"isVote":1,"tweetType":1,"viewCount":2032,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/695851697"}
精彩评论